Atria Investments’s BioTelemetry, Inc. BEAT Stock Holding History

Atria Investments’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-115,926	Closed	-$22M	–	1122
2019 Q1	$22M	Buy	+115,926	New	+$7.96M	0.93%	19

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Atria Investments's BEAT Position: Q2 2019 in Review

Atria Investments sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 115,926 shares — an estimated $22M sold.

Atria Investments first reported a position in BEAT in Q1 2019 and held it in 1 quarter. The position peaked at $22M in Q1 2019. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Atria Investments reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Atria Investments sold 115,926 BioTelemetry, Inc. shares in Q2 2019, an estimated $22M.
Atria Investments first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 1 quarter.
Atria Investments's BioTelemetry, Inc. position peaked at $22M in Q1 2019.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Atria Investments's 13F filing for Q2 2019, filed 9 Aug 2019.